← Back to Clinical Trials
Recruiting NCT07489417

NCT07489417 Impact of Sleep Restriction on Blood Pressure Reactivity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07489417
Status Recruiting
Phase —
Sponsor University of Missouri-Columbia
Condition Sleep
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2026-03-04
Primary Completion 2027-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Sleep Restriction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2026-03-04 with a primary completion date of 2027-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the research study is to examine the effects of shortened sleep on blood pressure.

Eligibility Criteria

Inclusion Criteria: * Healthy adult men and women * 18-45 years of age * BMI \< 25 kg/m² (normal weight group) or ≥ 30 kg/m² (obesity group) * Non-pregnant, non-breastfeeding, and non-nicotine users * Self-reported history of normal sleep duration (7-9 hours/night) and bedtime prior to midnight * Premenopausal Exclusion Criteria: * No acute or chronic conditions * Taking no medications known to affect sleep, autonomic, metabolic, or cardiovascular function * Self-reported history of irregular sleep * Self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse, major cardiovascular event or surgical procedure within the past three months, or hypertension

Contact & Investigator

Central Contact

Jacqueline Limberg

✉ limberglab@missouri.edu

📞 1-573-882-2544

Frequently Asked Questions

Who can join the NCT07489417 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07489417 currently recruiting?

Yes, NCT07489417 is actively recruiting participants. Contact the research team at limberglab@missouri.edu for enrollment information.

Where is the NCT07489417 trial being conducted?

This trial is being conducted at Columbia, United States.

Who is sponsoring the NCT07489417 clinical trial?

NCT07489417 is sponsored by University of Missouri-Columbia. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology